VOYA Investment Management’s Cullinan Oncology CGEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-14,661
Closed -$110K 2477
2025
Q2
$110K Buy
14,661
+264
+2% +$2.12K ﹤0.01% 2464
2025
Q1
$109K Sell
14,397
-880
-6% -$8.44K ﹤0.01% 2419
2024
Q4
$186K Sell
15,277
-733
-5% -$10.5K ﹤0.01% 2415
2024
Q3
$268K Buy
16,010
+3,041
+23% +$53.9K ﹤0.01% 2322
2024
Q2
$226K Buy
+12,969
New +$276K ﹤0.01% 2411
2024
Q1
Sell
-10,061
Closed -$103K 2805
2023
Q4
$103K Sell
10,061
-693
-6% -$6.14K ﹤0.01% 2752
2023
Q3
$97.3K Hold
10,754
﹤0.01% 2740
2023
Q2
$116K Sell
10,754
-1,527
-12% -$16.2K ﹤0.01% 2747
2023
Q1
$126K Hold
12,281
﹤0.01% 2659
2022
Q4
$130K Hold
12,281
﹤0.01% 2694
2022
Q3
$157K Buy
12,281
+1,072
+10% +$14.4K ﹤0.01% 2674
2022
Q2
$144K Buy
+11,209
New +$127K ﹤0.01% 2522
2021
Q4
Sell
-9,518
Closed -$215K 2783
2021
Q3
$215K Buy
+9,518
New +$255K ﹤0.01% 2531
2021
Q2
Sell
-5,466
Closed -$228K 2826
2021
Q1
$228K Buy
+5,466
New +$222K ﹤0.01% 2460

Other funds holding CGEM

VOYA Investment Management's CGEM Position: Q3 2025 in Review

VOYA Investment Management sold out of Cullinan Oncology (CGEM) in Q3 2025, closing a stake of 14,661 shares — an estimated $110K sold.

VOYA Investment Management first reported a position in CGEM in Q1 2021 and held it in 14 quarters. The position peaked at $268K in Q3 2024. 145 funds tracked by Wall St. Rank hold CGEM as of Q3 2025.

  • VOYA Investment Management reported no remaining Cullinan Oncology position as of Q3 2025 after selling out during the quarter.
  • VOYA Investment Management sold 14,661 Cullinan Oncology shares in Q3 2025, an estimated $110K.
  • VOYA Investment Management first reported a position in Cullinan Oncology in Q1 2021 and held it in 14 quarters.
  • VOYA Investment Management's Cullinan Oncology position peaked at $268K in Q3 2024.
  • 145 funds tracked by Wall St. Rank held Cullinan Oncology as of Q3 2025.

Based on VOYA Investment Management's 13F filing for Q3 2025, filed 9 Oct 2025.